Status:
UNKNOWN
Continuous Glucose Monitoring in Patients With Diabetes on Peritoneal Dialysis
Lead Sponsor:
Coordinación de Investigación en Salud, Mexico
Collaborating Sponsors:
Baxter Healthcare Corporation
Conditions:
Kidney Disease, Chronic
Peritoneal Dialysis
Eligibility:
All Genders
40-70 years
Brief Summary
Background: The patient presenting Chronic Kidney Disease, with etiology of diabetes mellitus (DM), has a metabolic alteration characterized by an elevation of glycemia and accompanied by cardiovascul...
Detailed Description
JUSTIFICATION The high prevalence of patients with end-stage CKD treated with PD and the dominant frequency of DM as a cause of CKD make it necessary to have documented guidelines for the metabolic co...
Eligibility Criteria
Inclusion
- Participants over 40 years of age, of any sex, diagnosed with Diabetic Nephropathy, and who are exclusively insulin-dependent for metabolic control, with at least three months of PD treatment.
Exclusion
- Patients with positive serology for HIV and hepatitis B and C, acute complications, and hospitalization for cardiovascular, metabolic or infectious disease in the month prior to inclusion in the study, cancer, pregnancy, or allergy.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06069518
Start Date
November 1 2023
End Date
November 1 2024
Last Update
October 5 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.